Pfizer Inc said on Friday the U.S. Food and Drug Administration has approved its lung-cancer treatment for patients with a specific gene mutation who had been previously treated for an aggressive form of the disease.
from Reuters: Health https://ift.tt/2RuSNaw
via
IFTTT
0 comments: